Acrivon Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	46.01	36.02	29.52	99.6	1.58
Short-Term Investments	134.53	91.44	98.23	-	-
Cash & Short-Term Investments	180.54	127.46	127.75	99.6	1.58
Cash Growth	19.60%	-0.23%	28.26%	6192.04%	-
Prepaid Expenses	1.82	2.23	4.34	0.81	0.14
Total Current Assets	182.36	129.69	132.1	100.41	1.72
Property, Plant & Equipment	7.44	7.91	6.86	5.79	0.06
Long-Term Investments	39.9	-	41.88	-	-
Long-Term Deferred Charges	0.47	0.25	-	-	-
Other Long-Term Assets	0.42	0.41	0.39	0.39	0.41
Total Assets	230.59	138.27	181.23	106.59	2.19
Accounts Payable	1.26	5.05	0.9	0.96	0.14
Accrued Expenses	8.76	7.38	4.14	1.22	0.42
Short-Term Debt	-	-	-	-	0.06
Current Portion of Leases	0.98	0.88	0.73	0.66	-
Current Unearned Revenue	-	-	0.07	0.07	-
Other Current Liabilities	0.28	-	0.67	-	-
Total Current Liabilities	11.28	13.3	6.52	2.91	0.61
Long-Term Leases	3.24	3.77	4.24	4.96	-
Total Liabilities	14.53	17.07	10.75	7.88	0.61
Common Stock	0.03	0.02	0.02	0	0
Additional Paid-In Capital	367.75	237.68	226.58	1.05	0.21
Retained Earnings	-151.7	-116.42	-56.03	-24.87	-8.62
Comprehensive Income & Other	-0.02	-0.08	-0.1	-	-
Total Common Equity	216.06	121.2	170.48	-23.81	-8.41
Shareholders' Equity	216.06	121.2	170.48	98.71	1.57
Total Liabilities & Equity	230.59	138.27	181.23	106.59	2.19
Total Debt	4.22	4.64	4.96	5.63	0.06
Net Cash (Debt)	176.32	122.81	122.79	93.98	1.53
Net Cash Growth	20.47%	0.02%	30.66%	6062.30%	-
Net Cash Per Share	6.84	5.56	29.79	53.90	1.06
Filing Date Shares Outstanding	30.97	22.64	21.92	1.77	1.43
Total Common Shares Outstanding	30.97	22.52	21.92	1.77	1.43
Working Capital	171.07	116.39	125.58	97.49	1.11
Book Value Per Share	6.98	5.38	7.78	-13.45	-5.87
Tangible Book Value	216.06	121.2	170.48	-23.81	-8.41
Tangible Book Value Per Share	6.98	5.38	7.78	-13.45	-5.87
Machinery	4.76	3.13	2.51	0.35	0.08
Construction In Progress	0.12	1.31	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.